Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy

被引：1
|
作者：
Fyfe I.
机构：
来源：
Nature Reviews Neurology | 2016年 / 12卷 / 7期
关键词：
D O I：
10.1038/nrneurol.2016.76
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：372 / 372
相关论文
共 50 条
  • [21] Is there a disease-modifying effect of long-term cyclic iloprost therapy in systemic sclerosis?
    Airo, P.
    Scarsi, M.
    Danieli, E.
    Rossi, M.
    Grotto, A.
    Zambruni, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 197 - 197
  • [22] Disease-modifying therapy for multiple sclerosis
    Holmoy, Trygve
    Myhr, Kjell-Morten
    Bo, Lars
    Nygaard, Gro Owren
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (08) : 723 - 726
  • [23] Disease-modifying therapy for multiple sclerosis
    Klineova, Sylvia
    Mitiku, Nesanet
    Miller, Aaron E.
    FUTURE NEUROLOGY, 2015, 10 (03) : 253 - 279
  • [24] Long-term effect of delaying disease-modifying therapy in patients with multiple sclerosis due to pregnancy planning
    Makkawi, Seraj
    Lavorato, Dina
    Greenfield, Jamie
    Parpal, Helene
    Metz, Luanne
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP14 - NP14
  • [25] Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis
    Sorensen, Per Soelberg
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 311 : S29 - S34
  • [26] Impact of adherence to disease-modifying drugs in multiple sclerosis: A study on Italian real-world data
    Belotti, Laura Maria Beatrice
    Di Martino, Mirko
    Zenesini, Corrado
    Vignatelli, Luca
    Baldin, Elisa
    Baccari, Flavia
    Ridley, Ben
    Nonino, Francesco
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 80
  • [27] The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis
    Fragoso, Yara Dadalti
    Boggild, Mike
    Angel Macias-Islas, Miguel
    Carrad, Adriana
    Schaerer, Kirsty Deborah
    Aguayo, Adriana
    Garcia de Almeida, Sandra Maria
    Alvarenga, Marcos Papais
    Papais Alvarenga, Regina Maria
    Alves-Leon, Soniza Vieira
    Arruda, Walter Oleschko
    Bidin Brooks, Joseph Bruno
    Regina Comini-Frota, Elizabeth
    Brito Ferreira, Maria Lucia
    Finkelsztejn, Alessandro
    Szymanski Finkelsztejn, Juliana Marcon
    de Freitas, Lucas Dias
    Gallina, Andre Serafin
    da Gama, Paulo Diniz
    Georgetto, Sergio
    Giacomo, Maria Cristina B.
    Gomes, Sidney
    Magno Goncalves, Marcus Vinicius
    Grzesiuk, Anderson Kuntz
    Kaimen-Maciel, Damacio Ramon
    Lopes, Josiane
    Lourenco, Giselle A.
    Malfetano, Fabiola Rachid
    Oliveira Morales, Nivea Macedo
    Morales, Rogerio de Rizo
    Silva Oliveira, Celso Luis
    Onaha, Patricia
    Patroclo, Cristiane
    Felix Ribeiro, Sonia Beatriz
    Gonsalves Jube Ribeiro, Taysa Alexandrino
    Salminen, Heidi Johanna
    Santoro, Patricia
    Seefeld, Marcos
    Soares, Paula Vallegas
    Tarulla, Adriana
    Ferreira Vasconcelos, Claudia Cristina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (02) : 154 - 159
  • [28] The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions
    Kobelt, G.
    Texier-Richard, B.
    Lindgren, P.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (06) : 741 - 751
  • [29] Real-world use of disease-modifying therapies in older persons with multiple sclerosis: Findings from the Swiss Multiple Sclerosis Registry
    Stanikic, Mina
    Salmen, Anke
    Chan, Andrew
    Kuhle, Jens
    Kesselring, Jurg
    Kamm, Christian
    Roth, Patrick
    Manjaly, Zina-Mary
    Calabrese, Pasquale
    Gobbi, Claudio
    Zecca, Chiara
    Mueller, Stefanie
    Pot, Caroline
    Rapold, Irene
    von Wyl, Viktor
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 377 - 378
  • [30] Prevalence of adverse events with long-term disease-modifying therapy and their impact on quality of life in patients with multiple sclerosis
    Oztekin, N.
    Oztekin, M. F.
    Eruyar, E.
    Bilen, S.
    Ak, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 415 - 416
12345